vision loss with glp 1 🚨 GLP1 & 🚨 According to a retrospective review of 500,000+ patients, there is an unexplained increase in vision loss in patients taking GLP1 patients by about in 1,000 Researchers Find Small Increased Risk

After being washed with cold PBS, the cells were fixed with paraformaldehyde

See the pattern

Although gastrointestinal exposure may reduce systemic absorption relative to parenteral administration, translocation across the intestinal barrier and subsequent organ accumulation cannot be excluded

M., Jordana, L., Friedrich, A

Central to Founds current offering is a collection of GLP-1 receptor agonists (like Ozempic and Wegovy), for which our team dedicated a considerable amount of research time, consuming more than 25 scientific studies related to their efficacy, safety, and mechanisms of action

For patients with no pre-existing SUD, GLP-1 use was associated with a 14% lower overall risk of developing any new substance use disorder